Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments

Shekoufeh Nikfar, Abbas Kebriaeezadeh, Rassoul Dinarvand, Mohammad Abdollahi, Mohammad Ali Sahraian, David Henry, Ali Akbari Sari*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments'. Together they form a unique fingerprint.

Medicine & Life Sciences